Antibodies to MMP-1 and MMP-3 reported in the sera of SSc patients were considered to be specific for SSc and were proposed to prevent the degradation of excessive collagen and ECM components in SSc (6, 24). This evidence concerns the gene MMP1 and systemic sclerosis.